These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 10633467)
21. Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP). Kakuta T; Suzuki Y; Tadaki F; Tanaka R; Tanaka S; Sakai H; Kurokawa K; Saito A Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii71-5. PubMed ID: 12771306 [TBL] [Abstract][Full Text] [Related]
22. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303 [TBL] [Abstract][Full Text] [Related]
23. Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Akizawa T; Fukagawa M; Koshikawa S; Kurokawa K Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):558-65. PubMed ID: 7859018 [TBL] [Abstract][Full Text] [Related]
24. Pathologic Features of Parathyroid Glands Associated With the Pathogenesis of Long-lasting Persistent Hyperparathyroidism After Kidney Transplantation in Long-term Dialysis Patients. Nakamura M; Ishida H; Takiguchi S; Tanaka K; Marui Y Transplant Proc; 2016 Apr; 48(3):874-7. PubMed ID: 27234756 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints]. Klempa I Chirurg; 1999 Oct; 70(10):1089-101. PubMed ID: 10550338 [TBL] [Abstract][Full Text] [Related]
27. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kitaoka M; Fukagawa M; Ogata E; Kurokawa K Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705 [TBL] [Abstract][Full Text] [Related]
28. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657 [TBL] [Abstract][Full Text] [Related]
29. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Basile C; Lomonte C; Vernaglione L; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Cazzato F Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients. Nakamura M; Tanaka K; Marui Y; Tomikawa S Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283 [TBL] [Abstract][Full Text] [Related]
31. [Optical and ultrastructural morphology in hyperparathyroidism during dialysis]. Schiaffino E; Zogno C; Schmid C; Mangili F; Cantaboni A Pathologica; 1992; 84(1092):445-58. PubMed ID: 1491886 [TBL] [Abstract][Full Text] [Related]
32. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. Tominaga Y; Kohara S; Namii Y; Nagasaka T; Haba T; Uchida K; Numano M; Tanaka Y; Takagi H World J Surg; 1996 Sep; 20(7):744-50; discussion 750-2. PubMed ID: 8678945 [TBL] [Abstract][Full Text] [Related]
33. Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease. Fukagawa M; Nakanishi S; Kazama JJ Kidney Int Suppl; 2006 Jul; (102):S3-7. PubMed ID: 16810308 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of refractory secondary hyperparathyroidism. Rodriguez M; Canalejo A; Garfia B; Aguilera E; Almaden Y Kidney Int Suppl; 2002 May; (80):155-60. PubMed ID: 11982830 [TBL] [Abstract][Full Text] [Related]
35. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. Numano M; Tominaga Y; Uchida K; Orihara A; Tanaka Y; Takagi H World J Surg; 1998 Oct; 22(10):1098-102; discussion 1103. PubMed ID: 9747174 [TBL] [Abstract][Full Text] [Related]
36. Medical management after parathyroid intervention. Tanaka M; Fukagawa M NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966 [TBL] [Abstract][Full Text] [Related]
37. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. Lomonte C; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C J Nephrol; 2005; 18(1):92-5. PubMed ID: 15772929 [TBL] [Abstract][Full Text] [Related]
38. Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism. Nakamura M; Fuchinoue S; Teraoka S Am J Kidney Dis; 2003 Oct; 42(4):739-45. PubMed ID: 14520624 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Koiwa F; Kakuta T; Tanaka R; Yumita S Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701 [TBL] [Abstract][Full Text] [Related]
40. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland. Yumita S Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]